title: Reply to F. Tomao et al.
authors.affiliation: Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France epujade@arcagy.org.
authors.forename: Eric
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.affiliation: Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany.
authors.forename: Felix
authors.initials: F
authors.lastname: Hilpert
authors.affiliation: Instituto Valenciano de Oncologia, Valencia, Spain.
authors.forename: Andres
authors.initials: A
authors.lastname: Poveda
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*